Evidence map›Paper›PMID 36011562›Full record

ReviewInternational journal of environmental research and public health2022

Long-Term Health Symptoms and Sequelae Following SARS-CoV-2 Infection: An Evidence Map.

Juan Victor Ariel Franco, Luis Ignacio Garegnani, Gisela Viviana Oltra, Maria-Inti Metzendorf, Leonel Fabrizio Trivisonno, Nadia Sgarbossa, Denise Ducks, Katharina Heldt, Rebekka Mumm, Benjamin Barnes and 1 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06166030 (EFFECTS OF WHEY PROTEIN SUPPLEMENTATION ON CARDIOPULMONARY, MUSCLE AND IMMUNOHEMATOLOGICAL RESPONSES OF POST-COVID-19 PATIENTS.), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06166030 phase3unknown statusnot on this mapstarted 2023, after this paper: background citation

Effects of whey protein supplementation on cardiopulmonary, muscle and immunohematological responses of post-covid-19 patients.

TypeinterventionalSponsorFederal University of São PauloRan2023 to 2024Enrolled58ConditionsLong Covid19, Dietary Supplements, Respiratory Tract Infections, InflammationArmsNutritional blend (ImmuneRecov).
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Short and Long-Term Wellbeing of Children following SARS-CoV-2 Infection: A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Juan Victor Ariel FrancoInstitute of General Practice, Medical Faculty, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0003-0411-899X
Luis Ignacio GaregnaniResearch Department, Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina.ORCID 0000-0003-4605-9473
Gisela Viviana OltraResearch Department, Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina.
Maria-Inti MetzendorfInstitute of General Practice, Medical Faculty, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0002-4154-5782
Leonel Fabrizio TrivisonnoDepartment of Health Science, Universidad Nacional de La Matanza, Buenos Aires B1754JEC, Argentina.ORCID 0000-0002-7983-4870
Nadia SgarbossaDepartment of Health Science, Universidad Nacional de La Matanza, Buenos Aires B1754JEC, Argentina.
Denise DucksDepartment of Epidemiology and Health Monitoring, Robert Koch-Institute, 13353 Berlin, Germany.
Katharina HeldtDepartment of Epidemiology and Health Monitoring, Robert Koch-Institute, 13353 Berlin, Germany.
Rebekka MummDepartment of Epidemiology and Health Monitoring, Robert Koch-Institute, 13353 Berlin, Germany.
Benjamin BarnesDepartment of Epidemiology and Health Monitoring, Robert Koch-Institute, 13353 Berlin, Germany.
Christa Scheidt-NaveDepartment of Epidemiology and Health Monitoring, Robert Koch-Institute, 13353 Berlin, Germany.
Robert Koch Institute · DEHeinrich Heine University Düsseldorf · DEHospital Italiano de Buenos Aires · ARUniversidad Nacional de La Matanza · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-COVID-19 conditions, also known as 'Long-COVID-19', describe a longer and more complex course of illness than acute COVID-19 with no widely accepted uniform case definition. We aimed to map the available evidence on persistent symptoms and sequelae following SARS-CoV-2 in children and adults. We searched the Cochrane COVID-19 Study Register and the WHO COVID-19 Global literature on coronavirus disease database on 5 November 2021. We included longitudinal and cross-sectional studies and we extracted their characteristics, including the type of core outcomes for post-COVID-19 conditions. We included 565 studies (657 records). Most studies were uncontrolled cohort studies. The median follow-up time was 13 weeks (IQR 9 to 24). Only 72% of studies were conducted in high-income countries, 93% included unvaccinated adults with mild-to-critical disease, only 10% included children and adolescents, and less than 5% included children under the age of five. While most studies focused on health symptoms, including respiratory symptoms (71%), neurological symptoms (57%), fatigue (54%), pain (50%), mental functioning (43%), cardiovascular functioning (40%), and post-exertion symptoms (28%), cognitive function (26%), fewer studies assessed other symptoms such as overall recovery (24%), the need for rehabilitation (18%), health-related quality of life (16%), changes in work/occupation and study (10%), or survival related to long-COVID-19 (4%). There is a need for controlled cohort studies with long-term follow-up and a focus on overall recovery, health-related quality of life, and the ability to perform daily tasks. Studies need to be extended to later phases of the pandemic and countries with low resources.

Indexed as

COVID-19AdolescentAdultChildCross-Sectional StudiesHumansPost-Acute COVID-19 SyndromeQuality of LifeSARS-CoV-2COVID-19evidence maplong-COVID-19

Identifiers

PMID36011562
PMCPMC9408764
OpenAlexW4290999284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.